Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Praeruptorin A Inhibits HCC Cell Metastasis via ERK/MMP1 Axi
2026-06-23
This study reveals that Praeruptorin A, an angular pyranocoumarin compound, suppresses the migration and invasion of human hepatocellular carcinoma (HCC) cells by modulating the ERK/MMP1 signaling pathway. These mechanistic insights highlight Praeruptorin A's potential as a targeted antimetastatic agent in advanced HCC research.
-
Capsazepine: Advancing TRPV1 Antagonism in Translational Pai
2026-06-23
This thought-leadership article explores Capsazepine’s role as a TRPV1 antagonist in the evolving landscape of pain and cancer research. It bridges mechanistic insights with actionable strategic guidance for translational researchers, highlighting experimental design, cross-channel selectivity, and clinical implications. Drawing on recent evidence and emerging trends, it positions APExBIO’s Capsazepine as a cornerstone tool for dissecting nociception and apoptosis, while outlining protocol parameters and future research opportunities.
-
Bleomycin Sulfate: Technical Guide for DNA Damage & Fibrosis
2026-06-22
Bleomycin Sulfate (SKU A8331) enables precise modeling of chemotherapy-induced DNA damage and pulmonary fibrosis in vitro and in vivo. It is ideal for researchers requiring robust DNA strand break induction but should not be used in applications demanding ethanol solubility or long-term solution stability.
-
M1 Macrophage Exosomal MMP8 Drives Enteric Neuronal Injury v
2026-06-22
This study dissects the neuroimmune interaction underlying gastrointestinal motility disorders, showing that M1 macrophage-derived exosomes rich in MMP8 activate the TGF-β pathway and induce enteric neuronal apoptosis. The findings clarify mechanisms of macrophage-driven neuronal injury and highlight MMP8 inhibition as a potential therapeutic strategy.
-
Proteomic Shifts in Lung Adenocarcinoma After HSP90 Inhibiti
2026-06-21
This study systematically maps the proteomic changes in lung adenocarcinoma cells following heat shock protein 90 (HSP90) inhibition, revealing key differentially expressed proteins and pathways linked to therapeutic response. The findings provide a foundation for identifying response biomarkers and optimizing inhibitor-based strategies in cancer research.
-
RepSox (ALK5 Inhibitor): Optimizing iPSC Platelet Differenti
2026-06-20
RepSox, a potent and selective ALK5 inhibitor, is transforming workflows for induced pluripotent stem cell (iPSC) reprogramming and platelet production. This article details experimental enhancements, practical troubleshooting, and data-driven use-cases for RepSox in scalable, cost-effective platelet manufacturing.
-
Lycorine Inhibits Pancreatic Cancer via ALDH3A1 and FAO Disr
2026-06-19
This study applies transcriptomics and molecular docking to elucidate how lycorine, a plant-derived alkaloid, suppresses pancreatic cancer by targeting ALDH3A1 and fatty acid oxidation pathways. The work provides new mechanistic insights into apoptosis induction and cell cycle arrest in pancreatic cancer, expanding targeted therapy strategies.
-
Clodronate Liposomes: Dissecting Macrophage Polarization in
2026-06-19
Explore how Clodronate Liposomes empower precise in vivo macrophage depletion and enable advanced analysis of macrophage polarization. This cornerstone article highlights the mechanistic rigor and experimental nuance needed for next-generation immune modulation research.
-
SB525334 TGF-beta1 Receptor Inhibitor: Optimizing Fibrosis M
2026-06-18
SB525334, a selective TGF-beta1 receptor inhibitor from APExBIO, empowers researchers to dissect and control TGF-β1-driven pathways in advanced fibrosis and diabetic wound healing models. Discover practical workflows, troubleshooting insights, and the translational impact of targeting TGF-β1/Smad2/3 signaling for superior assay reproducibility.
-
MRTFA-KCNMB1 Axis Regulates Cancer Cell Stiffness and Metast
2026-06-18
Gajda et al. identify the MRTFA-KCNMB1 signaling axis as a key regulator of cancer cell stiffness, revealing that modulation of potassium channel activity influences metastatic colonization and immune evasion. Their integrated genetic and pharmacological approach highlights new therapeutic possibilities for targeting biophysical properties of tumor cells.
-
MEG3 Modulates TGF-β1/PI3K/AKT Axis in NiO NP-Induced Fibros
2026-06-17
This study reveals how lncRNA MEG3 inhibits pulmonary fibrosis caused by nickel oxide nanoparticles (NiO NPs) through regulation of the TGF-β1-mediated PI3K/AKT pathway. The findings provide new mechanistic insight into nanoparticle-induced fibrogenesis and highlight points of pharmacological intervention for anti-fibrotic research.
-
3X (DYKDDDDK) Peptide: Precision Epitope Tagging for Structu
2026-06-17
Discover how the 3X (DYKDDDDK) Peptide advances protein science through superior epitope tagging and crystallography applications. This article uniquely explores the mechanistic and structural implications for sensitive protein detection and purification workflows.
-
MVC-Induced RhoA/ROCK1/MLC2 Activation Disrupts Tight Juncti
2026-06-16
This study uncovers how the Minute Virus of Canines (MVC) activates the RhoA/ROCK1/MLC2 pathway, leading to tight junction dissociation and facilitating viral entry by exposing Occludin as a co-receptor. The work delivers mechanistic insights valuable for developing targeted antiviral strategies and informs the application of RhoA inhibitors in dissecting virus-host interactions.
-
L-Phenylephrine: A Systems Biology Lens on α1A Agonist Resea
2026-06-16
Explore L-Phenylephrine as a selective adrenergic α1A receptor agonist, focusing on its systems-level impact in cardiovascular and neural models. Uniquely, this article integrates mechanistic, transcriptional, and sex-specific insights for advanced research design.
-
LY2109761: Advanced Smad2/3 Pathway Modulation in Disease Mo
2026-06-15
Explore how LY2109761, a potent TGF-β receptor type I and II dual inhibitor, enables unprecedented control of Smad2/3 phosphorylation in diverse disease models. This article delivers new insights into mechanism-based selectivity, practical assay design, and translational relevance beyond prior reviews.